Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Gynecologic Oncology
mi
from
Hinsdale, IL
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
Gynecologic Oncology
mi
from
Hinsdale, IL
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
St. Vincent Charity Hospital
mi
from
Cleveland, OH
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
St. Vincent Charity Hospital
mi
from
Cleveland, OH
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
Northern Indiana Cancer Research Consortium
mi
from
South Bend, IN
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
University of Louisville Hospital
mi
from
Louisville, KY
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
University of Louisville Hospital
mi
from
Louisville, KY
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Hematology Oncology Associates of Illinois
mi
from
Skokie, IL
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
Hematology Oncology Associates of Illinois
mi
from
Skokie, IL
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Barnes Jewish Hospital - Washington University
mi
from
St. Louis, MO
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
Barnes Jewish Hospital - Washington University
mi
from
St. Louis, MO
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Ohio State University
mi
from
Columbus, OH
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
University of Oklahoma College of Medicine
mi
from
Oklahoma City, OK
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
University of Oklahoma College of Medicine
mi
from
Oklahoma City, OK
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Gynecologic-Oncology Research and Development, LLC
mi
from
Greenville, SC
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
Gynecologic-Oncology Research and Development, LLC
mi
from
Greenville, SC
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Chattanooga GYN Oncology
mi
from
Chattanooga, TN
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
Chattanooga GYN Oncology
mi
from
Chattanooga, TN
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
US Army Institute of Surgical Research
mi
from
Ft Sam Houston, TX
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
US Army Institute of Surgical Research
mi
from
Ft Sam Houston, TX
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Carilion Gynecologic Oncology Associates
mi
from
Roanoke, VA
Efficacy of Ã…6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
A Phase 2 Randomized, Double-Blind Trial of the Clinical Activity and Safety of Ã…6 in Patients With Asymptomatic CA125 Progression of Epithelial Ovarian Cancer After First-Line Chemotherapy
Status: Archived
Updated: 1/1/1970
Carilion Gynecologic Oncology Associates
mi
from
Roanoke, VA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Glendale Memorial Hospital
mi
from
Glendale, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Updated: 1/1/1970
Glendale Memorial Hospital
mi
from
Glendale, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Hollywood Presbyterian Medical Center
mi
from
Los Angeles, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Updated: 1/1/1970
Hollywood Presbyterian Medical Center
mi
from
Los Angeles, CA
FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer
Phase I Study Of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura or Mediastinum
Status: Archived
National Cancer Institute (NCI)
mi
from
Bethesda, MD
FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer
Phase I Study Of Sequential Depsipeptide/Flavopiridol Infusion for Malignancies Involving Lungs, Esophagus, Pleura or Mediastinum
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Antiretroviral Therapy With or Without Bortezomib or Combination Chemotherapy and Rituximab or Sirolimus Only or Observation Only in Treating Patients With Castleman's Disease
Targeted Oncolytic Virotherapy And Natural History Study Of KSHV-Associated Multicentric Castleman's Disease With Laboratory And Clinical Correlates Of Disease Activity
Status: Archived
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Antiretroviral Therapy With or Without Bortezomib or Combination Chemotherapy and Rituximab or Sirolimus Only or Observation Only in Treating Patients With Castleman's Disease
Targeted Oncolytic Virotherapy And Natural History Study Of KSHV-Associated Multicentric Castleman's Disease With Laboratory And Clinical Correlates Of Disease Activity
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
Phase I Trial of Concurrent Taxotere With Radiation Therapy and Hormonal Therapy For Clinically Localized High Risk Prostate Cancer
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
Phase I Trial of Concurrent Taxotere With Radiation Therapy and Hormonal Therapy For Clinically Localized High Risk Prostate Cancer
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC
IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
A Phase I Prevention Trial of ACTIVIN Grape Seed Extract as an Aromatase Inhibitor In Healthy Postmenopausal Women at Risk for Breast Cancer
Status: Archived
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
A Phase I Prevention Trial of ACTIVIN Grape Seed Extract as an Aromatase Inhibitor In Healthy Postmenopausal Women at Risk for Breast Cancer
Status: Archived
Updated: 1/1/1970
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Surgery in Treating Patients With Resectable Pancreatic Neoplasms
Immunologic Studies of Tumors of the Pancreas
Status: Archived
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Surgery in Treating Patients With Resectable Pancreatic Neoplasms
Immunologic Studies of Tumors of the Pancreas
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Celecoxib Treatment for Lung Cancer
Celecoxib-Mediated Inhibition of T Regulatory Cells in Human Lung Cancer
Status: Archived
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Celecoxib Treatment for Lung Cancer
Celecoxib-Mediated Inhibition of T Regulatory Cells in Human Lung Cancer
Status: Archived
Updated: 1/1/1970
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Study of Satraplatin (JM-216) in Combination With Docetaxel
Phase I Study of the Oral Platinum Agent Satraplatin (JM-216) in Combination With Docetaxel in Treatment of Advanced Malignancies
Status: Archived
University of Wisconsin-Madison, Department of Dermatology
mi
from
Madison, WI
Study of Satraplatin (JM-216) in Combination With Docetaxel
Phase I Study of the Oral Platinum Agent Satraplatin (JM-216) in Combination With Docetaxel in Treatment of Advanced Malignancies
Status: Archived
Updated: 1/1/1970
University of Wisconsin-Madison, Department of Dermatology
mi
from
Madison, WI
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
A Prospective, Randomized Pilot Study of Enbrel VS Placebo in Patients Receiving Radiation Therapy to Combat Fatigue and Cachexia
Status: Archived
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
A Prospective, Randomized Pilot Study of Enbrel VS Placebo in Patients Receiving Radiation Therapy to Combat Fatigue and Cachexia
Status: Archived
Updated: 1/1/1970
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Palliative Care Study in Patients With Advanced Cancer
A Phase II Double Blind, Placebo Controlled, Randomized, Multicenter Study With AVR118 Solution in Patients With Advanced Malignancies Who Are Not Candidates for Chemotherapy
Status: Archived
Medical Center of Vincennes
mi
from
Vincennes, IN
Palliative Care Study in Patients With Advanced Cancer
A Phase II Double Blind, Placebo Controlled, Randomized, Multicenter Study With AVR118 Solution in Patients With Advanced Malignancies Who Are Not Candidates for Chemotherapy
Status: Archived
Updated: 1/1/1970
Medical Center of Vincennes
mi
from
Vincennes, IN
Palliative Care Study in Patients With Advanced Cancer
A Phase II Double Blind, Placebo Controlled, Randomized, Multicenter Study With AVR118 Solution in Patients With Advanced Malignancies Who Are Not Candidates for Chemotherapy
Status: Archived
Queens Medical Associates
mi
from
Fresh Meadows, NY
Palliative Care Study in Patients With Advanced Cancer
A Phase II Double Blind, Placebo Controlled, Randomized, Multicenter Study With AVR118 Solution in Patients With Advanced Malignancies Who Are Not Candidates for Chemotherapy
Status: Archived
Updated: 1/1/1970
Queens Medical Associates
mi
from
Fresh Meadows, NY
Palliative Care Study in Patients With Advanced Cancer
A Phase II Double Blind, Placebo Controlled, Randomized, Multicenter Study With AVR118 Solution in Patients With Advanced Malignancies Who Are Not Candidates for Chemotherapy
Status: Archived
North Shore University Hospital
mi
from
Manhasset, NY
Palliative Care Study in Patients With Advanced Cancer
A Phase II Double Blind, Placebo Controlled, Randomized, Multicenter Study With AVR118 Solution in Patients With Advanced Malignancies Who Are Not Candidates for Chemotherapy
Status: Archived
Updated: 1/1/1970
North Shore University Hospital
mi
from
Manhasset, NY
Palliative Care Study in Patients With Advanced Cancer
A Phase II Double Blind, Placebo Controlled, Randomized, Multicenter Study With AVR118 Solution in Patients With Advanced Malignancies Who Are Not Candidates for Chemotherapy
Status: Archived
Bronx Municipal Hospital Center
mi
from
Bronx, NY
Palliative Care Study in Patients With Advanced Cancer
A Phase II Double Blind, Placebo Controlled, Randomized, Multicenter Study With AVR118 Solution in Patients With Advanced Malignancies Who Are Not Candidates for Chemotherapy
Status: Archived
Updated: 1/1/1970
Bronx Municipal Hospital Center
mi
from
Bronx, NY
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
A Dose Finding Study (Phase I) of the Combination of ZD1839 (Iressa®) and an Oral Formulation of Irinotecan (Camptosar™) in Children With Refractory Solid Tumors
Status: Archived
St. Jude Childrens Research Hosp, Memphis
mi
from
Memphis, TN
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors
A Dose Finding Study (Phase I) of the Combination of ZD1839 (Iressa®) and an Oral Formulation of Irinotecan (Camptosar™) in Children With Refractory Solid Tumors
Status: Archived
Updated: 1/1/1970
St. Jude Childrens Research Hosp, Memphis
mi
from
Memphis, TN
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
Improving the Delivery of Effective Care to Minorities
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
Improving the Delivery of Effective Care to Minorities
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
Phase I/II Study of AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
Status: Archived
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
Phase I/II Study of AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
Phase II Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising PSA on Hormone Therapy
Status: Archived
Northwestern University
mi
from
Chicago, IL
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
Phase II Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising PSA on Hormone Therapy
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
Phase II Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising PSA on Hormone Therapy
Status: Archived
North Shore University Health Systems
mi
from
Evanston, IL
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
Phase II Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising PSA on Hormone Therapy
Status: Archived
Updated: 1/1/1970
North Shore University Health Systems
mi
from
Evanston, IL
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer (CEPO906AUS10)
Status: Archived
Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer (CEPO906AUS10)
Status: Archived
Updated: 1/1/1970
Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer
Status: Archived
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
A Phase II Trial of Exemestane (Aromasin) in Combination With Celecoxib (Celebrex) as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
Status: Archived
Ohio State University
mi
from
Columbus, OH
Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
A Phase II Trial of Exemestane (Aromasin) in Combination With Celecoxib (Celebrex) as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Hexvix Cystoscopy for Detection of Bladder Cancer
Status: Archived
Emory Umiversity School of Medicine
mi
from
Atlanta, GA
Hexvix Cystoscopy for Detection of Bladder Cancer
Status: Archived
Updated: 1/1/1970
Emory Umiversity School of Medicine
mi
from
Atlanta, GA
MRI-Guided Radiation Therapy in Treating Patients With Prostate Cancer
A Phase I Study of Image Guided Dose Escalation With Intensity Modulated Radiation Therapy (IMRT) to Histologically Confirmed Regions of Prostate Cancer
Status: Archived
National Cancer Institute (NCI)
mi
from
Bethesda, MD
MRI-Guided Radiation Therapy in Treating Patients With Prostate Cancer
A Phase I Study of Image Guided Dose Escalation With Intensity Modulated Radiation Therapy (IMRT) to Histologically Confirmed Regions of Prostate Cancer
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)
Pilot Study of Using Granulocyte Colony Stimulating Factor-Primed Bone Marrow in Histocompatible Sibling Allogeneic Bone Marrow Transplantation for Patients With Hematologic Malignancies and Non-Malignancies
Status: Archived
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)
Pilot Study of Using Granulocyte Colony Stimulating Factor-Primed Bone Marrow in Histocompatible Sibling Allogeneic Bone Marrow Transplantation for Patients With Hematologic Malignancies and Non-Malignancies
Status: Archived
Updated: 1/1/1970
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Albert Einstein College of Medicine
mi
from
Bronx, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Albert Einstein College of Medicine
mi
from
Bronx, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Harlem Hospital, Columbia University
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Harlem Hospital, Columbia University
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Metropolitan Hosp. NICHD CRS
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Metropolitan Hosp. NICHD CRS
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Montefiore Medical Center
mi
from
Bronx, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Montefiore Medical Center
mi
from
Bronx, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
North General Hospital
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
North General Hospital
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Elmhurst Memorial Hospital
mi
from
Elmhurst, IL
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Elmhurst Memorial Hospital
mi
from
Elmhurst, IL
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Queens Hospital Center
mi
from
Queens, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Queens Hospital Center
mi
from
Queens, NY
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
A Phase I/II Study of Nelfinavir in Liposarcoma
Status: Archived
City of Hope Medical Canter
mi
from
Duarte, CA
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
A Phase I/II Study of Nelfinavir in Liposarcoma
Status: Archived
Updated: 1/1/1970
City of Hope Medical Canter
mi
from
Duarte, CA